GlyEco Announces Preliminary Second Quarter 2017 Financial Information

July 13, 2017 9:00 AM

ROCK HILL, SC / ACCESSWIRE / July 13, 2017 / GlyEco, Inc. ("GlyEco" or the "Company") (OTC PINK: GLYE), a leading specialty chemical company, announced today preliminary financial information for the quarter ended June 30, 2017. Based on preliminary financial information, GlyEco expects to report total revenues for the second quarter of 2017 in the range of $2.6 million to $2.8 million, a positive gross profit for each of its operating...

Read more

Global Ceramic Glass Producer Approves Lithium Product from Frontier

July 11, 2017 1:47 PM

SUDBURY, ON / ACCESSWIRE / July 11, 2017 / Frontier Lithium Inc. (TSX-V: FL) (the "Company") is pleased to announce that it has satisfied product criteria of a leading global consumer of high purity lithium concentrates by a recently completed industrial trial/test as part of a 280 tonne bulk sample of the PAK lithium deposit. "The results of lithium product testing from the PAK Lithium Project have been approved by a leading global ceramic...

Read more

Koppers Selects Planbox for Its Innovation Management Chemistry

June 27, 2017 8:45 AM

MONTREAL, QC / ACCESSWIRE / June 27, 2017 / Planbox is pleased to announce that Koppers Inc. ("Koppers") (NYSE: KOP), an integrated global provider of treated wood products, wood treatment chemicals, and carbon compounds, has selected Planbox as its Innovation Management solution provider. Koppers will use Planbox to collect and manage innovation ideas from the organization's 1,800 global employees in North America, South America, Europe, Asia,...

Read more

Frontier Lithium PFS Work Indicates Favourable Ground Conditions for Potential Open Pit Structure at PAK Lithium Project

June 22, 2017 10:30 AM

SUDBURY, ON / ACCESSWIRE / June 22, 2017 / Frontier Lithium Inc. (TSX-V: FL) (the "Company") is pleased to announce new drilling results for its PAK Lithium Project, in the Red Lake mining district. As part of ongoing Pre-Feasibility Study (PFS) activities, the design brief, conducted by Golder Associates (Sudbury, ON, Canada) and based on the 2017 winter drilling program, outlined slope design recommendations for the Company's lithium deposit...

Read more

QuantumSphere in the Process of Retaining NYSE Member Firm for the Purpose of Identifying Potential Acquisition Targets, Merger Candidates or Outright Sale of Remaining Technologies

June 21, 2017 8:30 AM

SANTA ANA, CA / ACCESSWIRE / June 21, 2017 / QuantumSphere, Inc. (OTC PINK: QSIM), a developer and manufacturer of advanced catalyst materials designed to increase process efficiencies and production output in commercial-scale chemical plants, today issued a business update to its shareholders. The Company is committed to working with investment bankers to vet and finance potential deals brought to the table. QuantumSphere is looking to...

Read more

GlyEco Announces Appointment of Brian Gelman as Chief Financial Officer

June 19, 2017 4:05 PM

ROCK HILL, SC / ACCESSWIRE / June 19, 2017 / GlyEco, Inc. ("GlyEco" or the "Company") (OTC PINK: GLYE), a leading specialty chemical company, announced today the appointment of Brian Gelman as Chief Financial Officer. Mr. Gelman will officially join the Company on July 5, 2017. "Brian is a seasoned executive with significant financial and operational expertise who will be an exceptional addition to our company," stated Ian Rhodes, the Company's...

Read more

QuantumSphere and Vivakor Execute MOU for Asset Deal; Recent Debt Conversions Improve Company Balance Sheet

June 14, 2017 8:00 AM

MOU creates opportunity for royalty payments upon successful technology commercialization SANTA ANA, CA / ACCESSWIRE / June 14, 2017 / QuantumSphere, Inc. (OTC PINK: QSIM), a developer and manufacturer of advanced catalyst materials designed to increase process efficiencies and production output in commercial-scale chemical plants, today issued a business and corporate update to its shareholders. In June 2017, the Series A preferred...

Read more

Frontier Lithium signs Exploration Agreement with neighbouring North Spirit Lake First Nation

June 6, 2017 9:55 AM

SUDBURY, ON / ACCESSWIRE / June 6, 2017 / Frontier Lithium Inc. (TSX.V: FL) (the "Company") is pleased to announce that it has signed an Exploration Agreement with North Spirit Lake First Nation ("NSLFN" or "the Community") regarding the Company's mineral exploration activities on its PAK Lithium Project (the "Project") in the Red Lake Mining District, Northwestern Ontario. Under the signed Exploration Agreement, the Company will continue to...

Read more

ChroMedX Appoints Former Special Forces Officer Captain (Retd) Greg Falck to Advisory Board

May 16, 2017 4:23 PM

TORONTO, ON / ACCESSWIRE / May 16, 2017 / ChroMedX Corp. (CSE: CHX) (OTCQB: MNLIF) (FSE: EIY2) (the "Company"), developer of the HemoPalm Handheld Blood Analyzer System, is pleased to announce the appointment of former Canadian Armed Forces officer, Capt (Retd) Greg Falck to the Company's advisory board. While in the military, Capt Falck led the development of a multitude of diverse technologies while commanding a special forces maintenance...

Read more

Frontier Announces Exercise of Warrants, Options and Shares for Debt Financing for Proceeds of $763,809

May 16, 2017 3:50 PM

SUDBURY, ON / ACCESSWIRE / May 16, 2017 / Frontier Lithium Inc. (TSX-V: FL) ("Frontier") is pleased to announce that a total of 2,508,497 common shares have been issued as a result of combination of exercise of share purchase warrants and options since March 1, 2017 at a weighted average price of $0.18 per common share. This results in $480,309 of aggregate proceeds to Frontier Lithium. Frontier is pleased to also report that it has received a...

Read more

ChroMedX Completes Receptor Component and Commences Packaging of HemoPalm Analyzer Prototype

May 8, 2017 4:21 PM

TORONTO, ON / ACCESSWIRE / May 8, 2017 / ChroMedX Corp. (the "Company") (CSE: CHX) (OTCQB: MNLIF) (FSE: EIY2), developer of the HemoPalm Handheld Blood Analyzer System, is pleased to announce the completion of the cartridge receptor component for the HemoPalm analyzer prototype. The Company also announces the engagement of rapid prototyping firm, Agile Manufacturing, to complete the final assembly and packaging of the HemoPalm Analyzer...

Read more

True Leaf Announces Private Placement

May 3, 2017 7:20 AM

VANCOUVER, BC / ACCESSWIRE / May 3, 2017 / True Leaf Medicine International Ltd. (CSE: MJ) (FSE: TLA) (the "Company") is pleased to announce that it intends to complete a non-brokered private placement of units of the company (each, a "Unit") at a price of C$0.30 per Unit, with each Unit being comprised of one common share of the Company (a "Common Share") and one warrant exercisable into one Common Share at an exercise price of $0.45 per Common...

Read more

ChroMedX Files Enhanced Patent on Cartridge Improvements; Extends Protection to 2037

April 24, 2017 4:36 PM

TORONTO, ON / ACCESSWIRE / April 24, 2017 / ChroMedX Corp. (CSE: CHX) (OTCQB: MNLIF) (FSE: EIY2) (the "Company"), developer of the HemoPalm Handheld Blood Analyzer System, is pleased to announce the filing of a second PCT (International) patent application describing its HemoPalm platform. The application's purpose is to protect innovations and improvements discovered during development and extend patent protection until 2037. ChroMedX filed a...

Read more

Cannabis Experts Join True Leaf Team for Final Marijuana Licensing Review Stage

April 24, 2017 3:35 AM

VANCOUVER, BC / ACCESSWIRE / April 24, 2017 / True Leaf Medicine Inc. (True Leaf), a division of True Leaf Medicine International Ltd. (CSE: MJ) (FSE: TLA), has engaged a number of cannabis experts to guide the company through the final stage in Health Canada's review of its application for a license to produce marijuana in Canada. Experts from industry-leading Pipe Dreemz Inc., Protect-IP Global Solutions Inc., Eurofins Scientific, and Ample...

Read more

True Leaf Close to Completing Process for Marijuana License

April 20, 2017 3:30 AM

VANCOUVER, BC / ACCESSWIRE / April 20, 2017 / True Leaf Medicine Inc. (CSE: MJ) (FSE: TLA) ("True Leaf"), a division of True Leaf Medicine International Ltd., is two steps away from completing the process to acquire a license to produce and grow marijuana in Canada. True Leaf is now proceeding to stage five of the process, the 'Review', two years after submitting its application to Health Canada. True Leaf is one out of over 100 companies that...

Read more

ChroMedX Finalizes HemoPalm Analyzer 2.0 Design

April 18, 2017 4:20 PM

TORONTO, ON / ACCESSWIRE / April 18, 2017 / ChroMedX Corp. (CSE: CHX) (OTCQB: MNLIF) (FSE: EIY2) (the "Company"), developer of the HemoPalm Handheld Blood Analyzer System, is pleased to announce the finalization of the new HemoPalm 2.0 design. The new design reflects the evolution of diagnostics moving from laboratory based analysis to point-of-care testing (POCT). The design includes a number of new and updated features for improving...

Read more

OMNOVA Solutions to Present at the Planet MicroCap Showcase 2017

April 18, 2017 9:30 AM

NEW YORK, NY / ACCESSWIRE / April 18, 2017 / OMNOVA Solutions Inc. (OMN) is a global innovator of performance-enhancing chemistries and surfaces used in products for a variety of commercial, industrial and residential applications announced today that it will be presenting at the inaugural Planet MicroCap Showcase being held on April 26-28, 2017 at the Planet Hollywood Resort & Casino in Las Vegas, NV. The company will be presenting at 4:00...

Read more

ChroMedX Strengthens Advisory Board with New Appointments

April 12, 2017 4:25 PM

TORONTO, ON / ACCESSWIRE / April 12, 2017 / ChroMedX Corp. (CSE: CHX) (OTCQB: MNLIF) (FSE: EIY2) (the "Company"), developer of the HemoPalm Handheld Blood Analyzer System, is pleased to announce the appointment of Dr. Brian William Cameron and John P. Ormston to the Company's advisory board. "We are very pleased to strengthen our advisory board with the appointment of John Ormston and Dr. Cameron. Dr. Cameron's practical experience and John's...

Read more

ChroMedX Finalizes Cartridge for HemoPalm Prototype

April 10, 2017 3:20 AM

TORONTO, ONTARIO / ACCESSWIRE / April 10, 2017 / ChroMedX Corp. (CSE: CHX) (OTCQB: MNLIF) (FSE: EIY2) (the "Company"), developer of the HemoPalm Handheld Blood Analyzer System, is pleased to announce the completion of the HemoPalm cartridge design for integration and use with the upcoming HemoPalm analyzer prototype. The HemoPalm Cartridge is the most integral part of the technology and is protected globally by issued and pending international...

Read more

GlyEco Reports Fourth Quarter 2016 Results

April 6, 2017 5:13 PM

Quarter and Full Year Positive Gross Margin Adjusted Revenues Increased 8% for the Quarter ROCK HILL, SC / ACCESSWIRE / April 6, 2017 / GlyEco, Inc. ("GlyEco" or the "Company") (OTC PINK: GLYE), a leading specialty chemical company, announced today the following financial results for the quarter and year ended December 31, 2016: Quarter ended December 31, ...

Read more